Zobrazeno 1 - 10
of 57
pro vyhledávání: '"G F, Wooten"'
Autor:
Margery H. Mark, P. Vieregge, Ravi Prakash, David J. Burn, Irene Litvan, J. E. Tobin, Patrick F. Chinnery, Mark F. Lew, Christine Klein, Anita L. DeStefano, Marie Saint-Hilaire, Richard H. Myers, Garth A. Nicholson, JT Slevin, Peter P. Pramstaller, Mark Guttman, Mei Sun, Stefano Goldwurm, Lawrence I. Golbe, Abbas Parsian, Holly A. Shill, S. Williamson, Brad A. Racette, G. F. Wooten, CJ Berg, Kenneth B. Baker, James F. Gusella, Oksana Suchowersky, Carlos Singer, Jeanne C. Latourelle, M. L. Giroux, Marcy E. MacDonald, Gianni Pezzoli, Ray L. Watts, John H. Growdon, Franca Cambi, Jemma B. Wilk, Joel S. Perlmutter
Publikováno v:
Neurology. 67:2206-2210
Background: Polymorphisms in the glutathione S-transferase pi gene ( GSTP1 ), encoding GSTP1-1, a detoxification enzyme, may increase the risk of Parkinson disease (PD) with exposure to pesticides. Using the Gene PD Study sample of familial PD cases,
Autor:
Christine Klein, Margery H. Mark, Robert G. Feldman, Mark F. Lew, Marie Saint-Hilaire, Peter Vieregge, Mark Guttman, Mark Stacy, Richard H. Myers, Anita L. DeStefano, Erwin B. Montgomery, Peter P. Pramstaller, John H. Growdon, Gang Xu, Lawrence I. Golbe, Brad A. Racette, J. F. Gusella, Lillian J. Currie, N. Labelle, Oksana Suchowersky, A. Parsian, Alice M. Lazzarini, Jeanne C. Latourelle, Samer Karamohamed, Carlos Singer, Jun Liu, G. F. Wooten, Cheryl H. Waters, Christina M. Shoemaker, Ray L. Watts, Alan Herbert, Kenneth B. Baker, Jemma B. Wilk, Joel S. Perlmutter
Publikováno v:
Movement Disorders. 20:1188-1191
Parkinson's disease (PD) is a neurodegenerative disorder in which relatives of the probands are affected approximately 4 times as frequently as relatives of control subjects. Several genes have been implicated as genetic risk factors for PD. We inves
Autor:
Mark Stacy, Robert G. Feldman, Samer Karamohamed, S. J. Fink, Christine Klein, Gang Xu, Jemma B. Wilk, Alan Herbert, Carlos Singer, N. Labelle, Alice Lazzarini, Joel S. Perlmutter, Lillian J. Currie, Kenneth B. Baker, Marie Saint-Hilaire, Richard H. Myers, Mark Guttman, James F. Gusella, Lawrence I. Golbe, Peter Vieregge, Erwin B. Montgomery, Anita L. DeStefano, Mark F. Lew, Oksana Suchowersky, A. Parsian, Margery H. Mark, K. M. Sullivan, Brad A. Racette, G. F. Wooten, Peter P. Pramstaller, Cheryl H. Waters, Christina M. Shoemaker, Ray L. Watts, John H. Growdon
Publikováno v:
Neurology. 61:1557-1561
Objective: To identify a haplotype influencing onset age for Parkinson’s disease (PD) in the PARK3 region on chromosome 2p13. Methods: Single nucleotide polymorphisms (SNP) spanning 2.2 Mb and located in or near potential candidate genes were used
Autor:
G. F. Wooten
Publikováno v:
Annals of the New York Academy of Sciences. 835:153-156
Taken together with electrophysiological data, these results suggest that in states of DA deficiency, systemically administered L-dopa or DA agonist drugs inhibit cell firing in the major output nuclei of the basal ganglia (GPI and SNPR). We propose
Autor:
Peter P. Pramstaller, S. Tobin, Kenneth B. Baker, Scott J. Sherman, Mark Guttman, Ravi Prakash, Christine Klein, David J. Burn, J. Williamson, Oksana Suchowersky, Ray L. Watts, Stefano Goldwurm, Anita L. DeStefano, Patrick F. Chinnery, P. Vieregge, Brad A. Racette, Carlos Singer, Garth A. Nicholson, Mark F. Lew, Marie Saint-Hilaire, J. F. Gusella, Richard H. Myers, M. L. Giroux, G. F. Wooten, Jeanne C. Latourelle, N. Labell, Holly A. Shill, Lawrence I. Golbe, Jemma B. Wilk, Joel S. Perlmutter, B. N.J. Growdon, Samer Karamohamed, Gianni Pezzoli, Margery H. Mark, Irene Litvan, Abbas Parsian
Publikováno v:
Neurology. 65:1823-1825
Brain-derived neurotrophic factor (BDNF) stimulates neuronal growth and protects nigral dopamine neurons in animal models of Parkinson disease (PD). Therefore, BDNF is a candidate gene for PD. The authors investigated five single-nucleotide polymorph
Autor:
J. S. Fink, J. H. Growdon, W. Koller, C. W. Olanow, J. B. Bennett, Roger Kurlan, Christopher G. Goetz, P. LeWitt, O. Suchowersky, G. Paulson, K. Shannon, G. F. Wooten, A. H. Rajput, Joseph H. Friedman, S. Gancher, M. F. Brin, J. Nutt, Robert L. Rodnitzky, C. Tanner
Publikováno v:
New England Journal of Medicine. 328:176-183
In 1987 we began a multicenter controlled clinical trial of deprenyl (a monoamine oxidase inhibitor) and tocopherol (a component of vitamin E that traps free radicals) in the treatment of early Parkinson's disease. We randomly assigned 800 patients t
Autor:
H. R. Brashear, G. F. Wooten, Carol A. Manning, M. Fowler, P. Damgaard, M.B.S. Lopes, J. W. Mandell, Bradley Miller, Russell H. Swerdlow
Publikováno v:
Neurology. 72(3)
Objective: To describe a multigenerational kindred with a frontotemporal dementia clinical syndrome (FTDS), extensive subcortical gliosis pathology, and autosomal dominant genetics. Methods: Clinical, imaging, and pathologic evaluations of multiple f
Autor:
G F Wooten, Mark A. Granner
Publikováno v:
Seminars in Neurology. 11:228-235
NMS is a rare and idiosyncratic reaction that occurs with the use of dopamine antagonists or the withdrawal of dopamine agonists from patients with IP. It is a clinical diagnosis based on the presence of parkinsonism and hyperpyrexia in the appropria
Autor:
Stuart Isaacson, Jemma B. Wilk, Mark Guttman, Joel S. Perlmutter, Christine Klein, Richard Roxburgh, Tiffany Massood, Kenneth B. Baker, Oksana Suchowersky, Brad A. Racette, S. Williamson, Ray L. Watts, Holly A. Shill, Jeanne C. Latourelle, Marie Saint-Hilaire, Patrick F. Chinnery, Richard H. Myers, Mark F. Lew, Michael W. Nagle, Carlos Singer, M. Nance, Jason M. Laramie, Barry Snow, J. F. Gusella, J. E. Tobin, John T. Slevin, Karen Østergaard, Franca Cambi, Peter P. Pramstaller, Stefano Goldwurm, David J. Burn, Jomana T. Al-Hinti, John H. Growdon, Audrey E. Hendricks, Anita L. DeStefano, Alastair Corbett, Garth A. Nicholson, Scott J. Sherman, Lawrence I. Golbe, Anette Torvin Møller, Margery H. Mark, Irene Litvan, G. F. Wooten, Edward Drasby, Gianni Pezzoli
Publikováno v:
Tobin, J E, Latourelle, J C, Lew, M F, Klein, C, Suchowersky, O, Shill, H A, Golbe, L I, Mark, M, Growdon, J H, Wooten, G F, Racette, B A, Perlmutter, J S, Watts, R, Guttman, M, Baker, K B, Goldwurm, S, Pezzoli, G, Singer, C, Saint-Hilaire, M H, Hendricks, A E, Williamson, S, Nagle, M W, Wilk, J B, Massood, T, Laramie, J M, DeStefano, A L, Litvan, I, Nicholson, G, Corbett, A, Isaacson, S, Burn, D J, Chinnery, P F, Pramstaller, P P, Sherman, S, Al-hinti, J, Drasby, E, Nance, M, Møller, A T, Østergaard, K, Roxburgh, R, Snow, B, Slevin, J T, Cambi, F, Gusella, J F & Myers, R H 2008, ' Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study ', Neurology, vol. 71, no. 1, pp. 28-34 . https://doi.org/10.1212/01.wnl.0000304051.01650.23
Background: Microtubule-associated protein tau ( MAPT ) has been associated with several neurodegenerative disorders including forms of parkinsonism and Parkinson disease (PD). We evaluated the association of the MAPT region with PD in a large cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d281389c08229152d5731adf96cc0f95
https://europepmc.org/articles/PMC2654275/
https://europepmc.org/articles/PMC2654275/
Autor:
Bernard Ravina, G. F. Wooten, Yuko Y. Palesch, Peng Huang, Karl Kieburtz, Kathleen L. Shannon, G. C. Goetz, Caroline M. Tanner, Jordan J. Elm, Barbara C. Tilley
Publikováno v:
Neurology. 66(5)
Many agents are being considered for treatment of Parkinson disease (PD). Given the large number of agents and the limited resources to evaluate new agents, it is essential to reduce the likelihood of advancing ineffective agents into large, long-ter